期刊文献+

血清瘦素及其可溶性受体异常与2型糖尿病合并脂肪肝的关系及益气养阴活血法的干预作用 被引量:6

STUDIES ON RELATIONSHIP BETWEEN ABNORMITY OF SERUM LEPTIN/SLR AND ONSET OF FATTY LIVER IN TYPE 2 DIABETES MELLITUS AND INTERVENTION OF YIQI YANGYIN HUOXUE METHOD
下载PDF
导出
摘要 目的:探讨血清瘦素(leptin)及其可溶性受体(SLR)异常与2型糖尿病合并脂肪肝(DFL)之间的关系,及益气养阴活血法中药组方的干预作用。方法:收集196例2型糖尿病患者进行回顾性研究,其中未合并脂肪肝者100例作为对照组,确诊合并脂肪肝者96例病例(DFL)作为实验组,实验组的96例病例随机分成基础治疗组(50例)和中药治疗组(46例),两组均接受3个月的基础治疗,中药治疗组在基础治疗之外同时加以3个月的益气养阴活血中药组方水煎口服治疗,治疗前后进行肝脏B超检查,并ELISA法检测血清瘦素及可溶性瘦素受体的改变情况。结果:实验组与对照组相比较,血清Leptin及SLR有显著性差异(P<0·01,P<0·01),且实验组中,血TG变化与Leptin呈正相关(r=0·742,P<0·01)。两治疗组治疗后脂肪肝病变得以不同程度逆转,中药治疗组呈显著逆转(P<0·01);基础治疗组治疗前后血清Leptin和SLR、TC、TG无明显改善(P>0·05),而中药治疗组治疗后改善明显(均P<0·01)。结论:血清瘦素及其受体异常是2型糖尿病并发脂肪肝的原因之一,益气养阴活血法中药组方对这种生化异常有显著改善作用,这可能是益气养阴活血法治疗2型糖尿病并发脂肪肝的主要机制之一。 Objective:To explore the relationship between the abnormity of serum leptin and soluble leptin receptor(SLR) and onset of fatty liver in type 2 diabetes mellitus,observe the intervention effect of yiqi yangyin huoxue method on it.Methods:196 cases with type 2 diabetes mellitus were selected to be retrospectively researched,100 cases type 2 diabetes mellitus without fatty liver were taken as control group,96 cases with fatty liver in type 2 diabetes mellitus were taken as observed group,than 96cases were divided into two groups again,one was given the basic treatment,the other was given Chinese herbs of yiqi yangyin huoxue on the basis of basic treatment,the treatment course was three months.The severity of fatty liver of patient was determined by type B ultrasound before and after treated,the serum leptin and SLR levels were detected by ELISA,meanwhile determined the levels of blood sugar,lipid and insulin,etc.Results:There were obvious difference between the control and observed groups on serum leptin and SLR levels,the changes of TG was showed positive correlation with serum leptin changes.The severity of fatty liver of patient in the two groups was improved,the effect of Chinese herbs group was significant.The leptin and SLR levels in the basic treatment group had no obvious changes,the changes of them in the Chinese herbs group were significant.The blood lipid was obviously improved in the Chinese herbs group.Conclusion:The abnormity of serum leptin and soluble leptin receptor(SLR) was one of the causes that type 2 diabetes mellitus combined with fatty liver,yiqi yangyin huoxue method could improve the abnormal changes.
出处 《中国中医药科技》 CAS 2011年第3期177-178,203,共3页 Chinese Journal of Traditional Medical Science and Technology
基金 浙江省中医药青年基金项目研究计划No.B2005Y044
  • 相关文献

参考文献9

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 2高伟,任瑞珍,唐与晓,王秋灵,王玮,孟晓梅.2型糖尿病脂肪肝的筛查及相关因素分析[J].中华糖尿病杂志(1006-6187),2005,13(2):105-107. 被引量:42
  • 3Leyva F, Godsland IF, Ghatei M, et al. Hypedeptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol,1998,18(6) :928.
  • 4周鹏,朱大龙,何戎华,陈南衡.瘦素与胰岛素抵抗及糖代谢异常的关系[J].中华内分泌代谢杂志,2002,18(4):305-306. 被引量:8
  • 5Chehab F, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet, 1996,12 ( 3 ) : 318.
  • 6赵彩彦,李丽.瘦素与脂肪性肝病[J].中华肝脏病杂志,2004,12(8):510-512. 被引量:13
  • 7Tang M, Potter J, Mezey E. Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation. Biochem Biopys Res Commum,2002,297(4) :906.
  • 8Tang M, Potter J, Mezey E. Activation of the human alphal ( 1 ) collagen promoter by leptin is not mediated by transforming growth factor beta responsive elements. Biocbem Biopys Res Commum, 2003,312(3) :629.
  • 9Kakuma T, Lee Y, Higa M, et al. Leptin, troglitazone and the expressin of sterol regulatory element blinding proteins in liver pancreatic islets. Proc Natl Acad Sci USA,2000,97(15) :8536.

二级参考文献45

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care, 1991,14:1132-1143.
  • 4Muller G, Ertl J, Gerl M, et al. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem, 1997,272:10585-10593.
  • 5Ostlund RE, Yang JW, Klein S, et al. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab, 1996,81:3909-3913.
  • 6Kieffer TJ, Heller RS, Leech CA, et al. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes, 1997,46:1087-1093.
  • 7McCullough,AJ.Update on non-alcoholic fatty liver disease.J Clin Gastroenterol,2002,34:225- 262.
  • 8Bernal-Reyes R,Saenz-Labra A,Bernaydo-Escudero R.Prevalence of non-alcoholic steatohepatitis.Comparative study with diabetic patients. Review Gastroenterol Mexico,2000, 65: 58-62.
  • 9Luyckx FH,Lefebvre PJ,Scheen AJ,et al. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Meteb, 2000, 26:98-106.
  • 10Kaplan LM. Leptin,obesity,and liver disease.Gastroenterology, 1998, 115:997-1001.

共引文献1558

同被引文献39

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部